RPL35AP37

Across TCGA pan-cancer cohorts, RPL35AP37 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL35AP37’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where RPL35AP37 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL35AP37 is over-expressed in tumor.

ESCA, LUAD, and KICH are the cancer types where RPL35AP37 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL35AP37 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+0.315	.019	3	view →
LUAD	All	All	+0.061	.005	3	view →
KICH	Female	III,IV	+0.150	<.001	1	view →
HNSC	All	II,III,IV	+0.020	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPL35AP37–ESCA

Open the ESCA breakdown →